샘플 요청 목록

 카트 문의
시장보고서
상품코드
1646736

세계의 아르보바이러스 검사 시장

Arbovirus Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 아르보바이러스 검사 시장은 2030년까지 18억 달러에 도달

2024년에 13억 달러로 추정되는 세계의 아르보바이러스 검사 시장은 분석 기간인 2024-2030년에 CAGR 5.9%로 성장하며, 2030년에는 18억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 ELISA 기반 검사는 CAGR 5.5%를 기록하며, 분석 기간 종료까지 10억 달러에 달할 것으로 예측됩니다. RT-PCR 기반 검사 분야의 성장률은 분석 기간 중 CAGR 6.3%로 추정됩니다.

미국 시장은 3억 3,030만 달러로 추정, 중국은 CAGR 9.0%로 성장 예측

미국의 아르보바이러스 검사 시장은 2024년에 3억 3,030만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 9.0%로 추이하며, 2030년에는 4억 1,900만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.5%와 4.5%로 예측됩니다. 유럽에서는 독일이 CAGR 4.0%로 성장할 것으로 예측됩니다.

세계의 아르보바이러스 검사 시장 - 주요 동향과 촉진요인 정리

현대 공중보건에서 아르보바이러스 검사가 중요한 이유는 무엇인가?

아르보바이러스(절지동물 매개 바이러스)는 감염된 모기나 진드기 등 절지동물에 물려서 사람에게 감염되며, 전 세계에서 공중보건에 심각한 문제가 되고 있습니다. 지카, 뎅기열, 치쿤구니야, 웨스트 나일 바이러스 등의 질병이 특히 열대 및 아열대 지역에서 유행하고 있는 지금, 효과적인 아르보바이러스 검사의 필요성이 그 어느 때보다 높아지고 있습니다. 이러한 바이러스를 조기에 정확하게 검출하는 것은 유행의 억제, 치료 지침 및 예방책의 시행에 필수적입니다. 아르보바이러스 검사에는 PCR(중합효소연쇄반응)과 같은 분자생물학적 방법, 항체를 검출하는 혈청학적 검사, 세포배양에서의 바이러스 분리 등 다양한 진단법이 있습니다. 이러한 검사의 중요성은 감염을 확인하고, 다양한 아르보바이러스를 구별하며, 역학 감시를 위한 중요한 데이터를 제공하는 능력에 있습니다. 기후 변화, 도시화, 전 세계 여행 증가 등의 요인으로 인해 전 세계에서 아르보바이러스 감염률이 증가함에 따라 이러한 질병의 영향을 줄이기 위한 검사의 역할이 공중 보건 노력에서 점점 더 중요해지고 있습니다.

기술의 발전은 어떻게 아르보바이러스 검사를 강화하는가?

기술의 발전으로 아르보바이러스 검사의 능력과 정확도가 크게 향상되어 보다 신속하고 신뢰할 수 있는 진단과 더 나은 발병 관리가 가능해졌습니다. 분자진단, 특히 실시간 PCR은 바이러스 RNA를 신속하고 특이성 있게 검출하여 종종 몇 시간 내에 바이러스 RNA를 검출함으로써 아르보바이러스 검사에 혁명을 일으켰습니다. 이러한 기술을 통해 가까운 친척 바이러스를 구별할 수 있으며, 이는 여러 아르보바이러스가 유행하는 지역에서 매우 중요합니다. 또한 차세대 염기서열 분석기(NGS)는 아르보바이러스 식별 및 특성 분석을 위한 강력한 툴로 부상하고 있으며, 바이러스의 유전학에 대한 자세한 인사이트을 제공하고 신규 및 신종 바이러스를 감지하는 데 도움을 주고 있습니다. 또한 휴대용 검사 장비와 현장 검사 장비의 혁신은 적시 진단이 중요한 원격지나 자원이 부족한 환경에서 아르보바이러스 진단에 대한 접근성을 넓히고 있습니다. 이러한 발전은 데이터 분석에 AI와 머신러닝을 통합하여 아르보바이러스 검사의 정확성과 효율성을 향상시킬 뿐만 아니라, 보다 적극적인 공중보건 대응을 가능하게 하고 있습니다.

아르보바이러스 검사의 미래를 좌우할 새로운 동향은?

공중 보건 전략, 기술 혁신, 환경 요인의 광범위한 변화를 반영하는 몇 가지 새로운 동향이 아르보바이러스 검사의 미래를 형성하고 있습니다. 중요한 동향 중 하나는 하나의 샘플에서 여러 병원체를 동시에 검출할 수 있는 멀티플렉스 검사에 대한 중요성이 강조되고 있다는 점입니다. 이는 진단 프로세스를 간소화하고 공중보건 의사결정을 위한 보다 종합적인 데이터를 제공하기 위한 것으로, 서로 다른 아르보바이러스의 동시 유행이 흔한 지역에서 특히 중요합니다. 또 다른 중요한 추세는 과거 감염을 보다 정확하게 감지하고 집단의 면역 수준을 측정할 수 있는 민감도와 특이도가 향상된 혈청학적 검사의 개발입니다. 또한 질병 감시를 위한 디지털 건강 플랫폼과 모바일 앱의 사용 확대는 아르보바이러스 사례의 추적과 보고를 강화하여 발병의 실시간 모니터링을 용이하게 하고 있습니다. 또한 기후, 모기 서식지 동향 등 환경 데이터와 진단 데이터의 통합이 확산되고 있으며, 아르보바이러스 감염 확산 예측 모델링이 가능해졌습니다. 이러한 추세는 아르보바이러스 검사 분야의 기술 혁신을 촉진하고, 세계 보건 안보의 중요한 요소로 자리매김할 수 있도록 하고 있습니다.

아르보바이러스 검사 시장의 성장을 가속하는 요인은 무엇인가?

아르보바이러스 검사 시장의 성장은 기술 발전, 공중 보건 요구의 진화, 환경 변화에 따른 몇 가지 요인에 의해 주도되고 있습니다. 첫째, 특히 기후 변화와 도시화의 영향을 받는 지역에서 전 세계에서 아르보바이러스 감염의 발생률이 증가함에 따라 신뢰할 수 있고 확장 가능한 검사 솔루션에 대한 수요가 증가하고 있습니다. 둘째, 분자진단학 및 현장 검사 기술의 발전으로 인해 아르보바이러스 검사의 접근성과 효율성이 확대되어 임상과 현장 모두에서 보다 빠르고 정확한 진단이 가능해졌습니다. 셋째, 특히 여행 및 관광에서 예방적 건강 조치에 대한 인식이 높아지고 시행되면서 선제적 검사 및 감시 시스템에 대한 수요가 증가하고 있습니다. 또한 매개체 감염병 대응에 중점을 둔 세계 보건 구상의 확대는 아르보바이러스 검사 인프라 및 조사에 대한 투자 증가를 촉진하고 있습니다. 이러한 요인들은 혁신적인 진단 툴의 개발 및 디지털 헬스 기술 통합의 진전과 함께 아르보바이러스 검사 시장의 강력한 성장에 박차를 가하고 있으며, 이는 신흥 전염병과의 싸움에서 중요한 요소로 자리매김하고 있습니다.

부문

검사 유형(ELISA 기반 검사, RT-PCR 기반 검사);최종사용자(공중위생 연구소, 병원, 진단 센터, 기타 최종사용자)

조사 대상 기업의 예(주목 합계 42사)

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.02.20

Global Arbovirus Testing Market to Reach US$1.8 Billion by 2030

The global market for Arbovirus Testing estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the RT-PCR based Tests segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$330.3 Million While China is Forecast to Grow at 9.0% CAGR

The Arbovirus Testing market in the U.S. is estimated at US$330.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$419.0 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Arbovirus Testing Market - Key Trends and Drivers Summarized

Why Is Arbovirus Testing Crucial in Modern Public Health?

Arboviruses, or arthropod-borne viruses, are transmitted to humans through the bites of infected mosquitoes, ticks, and other arthropods, posing significant public health challenges worldwide. With diseases such as Zika, Dengue, Chikungunya, and West Nile Virus becoming more prevalent, especially in tropical and subtropical regions, the need for effective arbovirus testing has never been more critical. Early and accurate detection of these viruses is essential for controlling outbreaks, guiding treatment, and implementing preventive measures. Arbovirus testing encompasses a range of diagnostic methods, including molecular techniques like PCR (Polymerase Chain Reaction), serological tests to detect antibodies, and virus isolation in cell cultures. The importance of these tests lies in their ability to confirm infections, differentiate between various arboviruses, and provide critical data for epidemiological surveillance. As the global incidence of arbovirus infections rises, driven by factors such as climate change, urbanization, and increased global travel, the role of testing in mitigating the impact of these diseases is becoming increasingly central to public health efforts.

How Are Technological Advances Enhancing Arbovirus Testing?

Technological advances are significantly enhancing the capabilities and accuracy of arbovirus testing, enabling faster, more reliable diagnosis, and better outbreak management. Molecular diagnostics, particularly real-time PCR, have revolutionized arbovirus testing by offering rapid and highly specific detection of viral RNA, often within hours. These techniques allow for the differentiation of closely related viruses, which is crucial in regions where multiple arboviruses are endemic. Additionally, next-generation sequencing (NGS) is emerging as a powerful tool in the identification and characterization of arboviruses, providing detailed insights into viral genetics and aiding in the detection of novel or emerging strains. Innovations in portable and point-of-care testing devices are also expanding access to arbovirus diagnostics in remote or resource-limited settings, where timely diagnosis is critical. These advancements, coupled with the integration of AI and machine learning in data analysis, are not only improving the accuracy and efficiency of arbovirus testing but also enabling more proactive public health responses.

What Emerging Trends Are Shaping the Future of Arbovirus Testing?

Several emerging trends are shaping the future of arbovirus testing, reflecting broader changes in public health strategies, technological innovation, and environmental factors. One significant trend is the increasing emphasis on multiplex testing, which allows for the simultaneous detection of multiple pathogens from a single sample. This is particularly important in regions where co-circulation of different arboviruses is common, as it streamlines the diagnostic process and provides more comprehensive data for public health decision-making. Another important trend is the development of serological tests with improved sensitivity and specificity, which can more accurately detect past infections and measure population immunity levels. Additionally, the growing use of digital health platforms and mobile apps for disease surveillance is enhancing the tracking and reporting of arbovirus cases, facilitating real-time monitoring of outbreaks. The integration of environmental data, such as climate and mosquito population trends, with diagnostic data is also becoming more prevalent, enabling more predictive modeling of arbovirus spread. These trends are driving innovation in the field of arbovirus testing, ensuring that it remains a critical component of global health security.

What Factors Are Driving Growth in the Arbovirus Testing Market?

The growth in the arbovirus testing market is driven by several factors that align with technological advancements, evolving public health needs, and environmental changes. Firstly, the increasing global incidence of arbovirus infections, particularly in regions affected by climate change and urbanization, is propelling demand for reliable and scalable testing solutions. Secondly, advancements in molecular diagnostics and point-of-care testing technologies are expanding the accessibility and efficiency of arbovirus testing, enabling quicker and more accurate diagnosis in both clinical and field settings. Thirdly, the growing awareness and implementation of preventive health measures, particularly in travel and tourism, are driving demand for preemptive testing and surveillance systems. Additionally, the expansion of global health initiatives focused on combating vector-borne diseases is fostering increased investment in arbovirus testing infrastructure and research. These factors, combined with the ongoing development of innovative diagnostic tools and the integration of digital health technologies, are fueling robust growth in the arbovirus testing market, positioning it as a critical element in the global fight against emerging infectious diseases.

SCOPE OF STUDY:

The report analyzes the Arbovirus Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (ELISA-Based Tests, RT-PCR Based Tests); End-Use (Public Health Laboratory, Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Arbovirus Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Arbovirus Infections Spurs Growth in Testing Demand
    • Advancements in Molecular Diagnostics Propel Innovation in Arbovirus Testing
    • Increasing Adoption of Multiplex Testing Strengthens Business Case for Advanced Diagnostics
    • Expansion of Point-of-Care Testing Solutions Drives Accessibility in Remote Areas
    • Growing Use of AI and Machine Learning in Data Analysis Enhances Testing Accuracy
    • Increasing Focus on Travel-Related Health Measures Expands Market Opportunities
    • Advancements in Serological Testing Drive Demand for Enhanced Immunity Monitoring
    • Here's How Portable Testing Devices Are Enhancing Response Capabilities in Epidemic Zones
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for ELISA-based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for RT-PCR based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Arbovirus Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제